Chemical | 16 May 2021
MCFL posts Q4F21 net profit at Rs 14.72 Cr
MCFL reported total income of Rs.567.82 crores during the period ended March 31, 2020.
MCFL reported total income of Rs.567.82 crores during the period ended March 31, 2020.
The company posted net profit of Rs.47.99 crores for the FY ended March 31, 2021
The company has posted net loss of Rs. 6.12 crores for the period ended March 31, 2020.
Aarti Drugs has reported total income of Rs.2159.30 crores during the 12 months period ended March 31, 2021
The company plans to aggressively invest in longer gestation period projects like innovation, biosimilars, vaccines, etc.
Financial support is being provided as a grant from the Government of India
The subsidy is released to fertilizer companies as per Nutrient based subsidy rates so that they can make available fertilizers to farmers at affordable price
The country's cybersecurity policy needs to be tweaked keeping in view the recent Executive Order (EO) issued by President Biden to improve US cybersecurity so that public and private networks can be safe in India
The trial met its pre-specified primary endpoint, demonstrating that PDP-716 dosed once daily is equivalent to Alphagan P 0.1% dosed 3 times a day
Lurasidone Hydrochloride tablets are also indicated for adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder
Medical facility will have 100 beds in the first phase, which will be later expanded to accommodate 1,500 beds, in the same premises
The company is working closely with its six manufacturing partners in India
Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021
The company has posted net profit of Rs.35.03 crores for the period ended March 31, 2020
The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021
The order inflow for the quarter January-March 2021 at ? 50,651 crore
The company has prepaid the outstanding term loans (from the proceeds of the IPO and internal accruals) and is now a debt free company.
TCLS USA expects to start production by the late summer of 2023.
FY21 revenues from operations stood at Rs. 709.3 crore as against Rs. 600.1 crore for FY20, higher by 18.2%
International revenue grew 21.8/6.5% YoY to Rs. 7.3/25bn in 4Q/FY21.
Subscribe to our newsletter & stay updated.
